A sample list of molecular EQA programmes available from QCMD is displayed below. For further information, to register or to access our catalogue please login to your QCMD Laboratory Profile. If you do not have a Username and Password please click here.
Click to view / hide
Blood Borne Virus
B19 virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV034116_1 | QAV034116_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 8 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
HBV Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV124160_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV134167_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HIV Dried Blood Spot EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV214221_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAV024131_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme
Feature | Available Formats | Catalogue Number | QAV114146_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
HIV-1 DNA EQA programme
Feature | Available Formats | Catalogue Number | QAV034114_1 | QAV034114_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 8 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Hepatitis A virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV124156_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Hepatitis B Virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV994110_1 | QAV994110_2 | QAV994110_4 |
Total Number of Challenges | 1 | 2 | 4 |
Number of Panel Members | 8 | 4 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Hepatitis B Virus Dried Blood Spot EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV214223_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Hepatitis B virus Genotype EQA Programme
Feature | Available Formats | Catalogue Number | QAV064118_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Hepatitis C Virus Dried Blood Spot EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV214222_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Hepatitis C Virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV994112_1 | QAV994112_2 | QAV994112_4 |
Total Number of Challenges | 1 | 2 | 4 |
Number of Panel Members | 8 | 4 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Hepatitis C virus Genotype EQA Programme
Feature | Available Formats | Catalogue Number | QAV034117_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Hepatitis D Virus EQA Programme
Feature | Available Formats | Catalogue Number | QAV144170_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q4 |
Hepatitis E virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV124157_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q4 |
Human Immunodeficiency Virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV994108_1 | QAV994108_2 | QAV994108_4 |
Total Number of Challenges | 1 | 2 | 4 |
Number of Panel Members | 8 | 4 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Human Immunodeficiency Virus Type 2 EQA Programme
Feature | Available Formats | Catalogue Number | QAV204212_1 | QAV204212_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 8 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Click to view / hide
Central Nervous System
Arthropod-Borne Viruses EQA Programme
Feature | Available Formats | Catalogue Number | QAM194206_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
BK virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV144166_1 | QAV144166_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Borrelia burgdorferi spp. DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAB114147_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme
Feature | Available Formats | Catalogue Number | QAV174195_1 | QAV174195_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme
Feature | Available Formats | Catalogue Number | QAM174196_1 | QAM174196_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Chikungunya Virus EQA Programme
Feature | Available Formats | Catalogue Number | QAV154175_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Dengue Virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV114148_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Enterovirus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV984104_1 | QAV984104_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Enterovirus Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV164185_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Herpes Simplex Virus Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAV164184_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q1 |
Herpes simplex virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV994105_1 | QAV994105_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
JC virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV074106_1 | QAV074106_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Measles and Mumps EQA Programme
Feature | Available Formats | Catalogue Number | QAV144171_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Parechovirus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV114145_1 | QAV114145_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Toxoplasma gondii DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAP044123_1 | QAP044123_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Varicella-Zoster virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV034103_1 | QAV034103_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
West Nile Virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV104141_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Zika Virus EQA Programme
Feature | Available Formats | Catalogue Number | QAV164186_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Congenital Infections
Cytomegalovirus Dried Blood Spot EQA Programme
Feature | Available Formats | Catalogue Number | QAV064127_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Toxoplasma gondii DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAP044123_1 | QAP044123_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214217_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Drug Resistance
Cytomegalovirus Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV144169_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Extended Spectrum β-lactamase and Carbapenemase EQA Programme
Feature | Available Formats | Catalogue Number | QAB134162_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
HBV Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV124160_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV134167_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAV024131_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme
Feature | Available Formats | Catalogue Number | QAV114146_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
Herpes Simplex Virus Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAV164184_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q1 |
Methicillin Resistant Staphylococcus aureus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAB064124_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Mycobacterium Tuberculosis Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAB194209_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Vancomycin Resistant Enterococci EQA Programme
Feature | Available Formats | Catalogue Number | QAB134163_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Exotic / Emerging Diseases
Plasmodium spp. (Malaria) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214218_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Arthropod-Borne Viruses EQA Programme
Feature | Available Formats | Catalogue Number | QAM194206_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Babesia spp. (Babesiosis) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214219_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Chikungunya Virus EQA Programme
Feature | Available Formats | Catalogue Number | QAV154175_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Dengue Virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV114148_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Francisella tularensis EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAB214220_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
MERS Coronavirus EQA Programme
Feature | Available Formats | Catalogue Number | QAV154181_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q2 |
Poxviruses EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV224225_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Respiratory I Plus EQA Programme
Feature | Available Formats | Catalogue Number | QAM204216_1A | QAM204216_1B |
Total Number of Challenges | 1 | 1 |
Number of Panel Members | 10 | 10 |
Distribution / Testing Period | Q2 | Q4 |
SARS-CoV-2 Antigen Testing EQA Programme
Feature | Available Formats | Catalogue Number | QAS214224_1A | QAS214224_1B | QAS214224_1C | QAS214224_1D |
Total Number of Challenges | 1 | 1 | 1 | 1 |
Number of Panel Members | 5 | 5 | 5 | 5 |
Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
SARS-CoV-2 EQA Programme
Feature | Available Formats | Catalogue Number | QAV204215_1A | QAV204215_1B | QAV204215_1C | QAV204215_1D |
Total Number of Challenges | 1 | 1 | 1 | 1 |
Number of Panel Members | 5 | 5 | 5 | 5 |
Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214217_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
West Nile Virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV104141_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Yellow Fever Virus EQA Programme
Feature | Available Formats | Catalogue Number | QAV194207_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Zika Virus EQA Programme
Feature | Available Formats | Catalogue Number | QAV164186_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Gastrointestinal Diseases
Adenovirus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV054133_1 | QAV054133_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Bacterial Gastroenteritis EQA Programme
Feature | Available Formats | Catalogue Number | QAB124153_1 | QAB124153_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Clostridium difficile DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAB084125_1 | QAB084125_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Diarrheagenic Escherichia coli EQA Programme
Feature | Available Formats | Catalogue Number | QAB154179_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Helicobacter pylori EQA Programme
Feature | Available Formats | Catalogue Number | QAB164190_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Norovirus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV084139_1 | QAV084139_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Parasitic Gastroenteritis EQA Programme
Feature | Available Formats | Catalogue Number | QAP124154_1 | QAP124154_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Viral Gastroenteritis EQA Programme
Feature | Available Formats | Catalogue Number | QAV124152_1 | QAV124152_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Click to view / hide
Immunocompromised Associated Diseases
Aspergillus spp. DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAF104140_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
BK virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV144166_1 | QAV144166_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Babesia spp. (Babesiosis) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214219_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Candida spp. EQA Programme
Feature | Available Formats | Catalogue Number | QAF124151_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Cytomegalovirus Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV144169_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Cytomegalovirus Whole Blood EQA Programme
Feature | Available Formats | Catalogue Number | QAV124150_1 | QAV124150_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV024121_1 | QAV024121_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus Whole Blood EQA Programme
Feature | Available Formats | Catalogue Number | QAV134161_1 | QAV134161_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Cytomegalovirus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV014120_1 | QAV014120_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Herpes Virus 6 DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV084119_1 | QAV084119_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
JC virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV074106_1 | QAV074106_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAF114144_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Torque Teno Virus EQA Programme
Feature | Available Formats | Catalogue Number | QAV184203_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 6 |
Distribution / Testing Period | Q4 |
Toxoplasma gondii DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAP044123_1 | QAP044123_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Transplantation EQA Programme
Feature | Available Formats | Catalogue Number | QAM174198_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214217_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Multiple Pathogen/Syndromic
Arthropod-Borne Viruses EQA Programme
Feature | Available Formats | Catalogue Number | QAM194206_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Bacterial Gastroenteritis EQA Programme
Feature | Available Formats | Catalogue Number | QAB124153_1 | QAB124153_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme
Feature | Available Formats | Catalogue Number | QAV174195_1 | QAV174195_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme
Feature | Available Formats | Catalogue Number | QAM174196_1 | QAM174196_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAB174191_1 | QAB174191_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
MALDI-TOF EQA Programme
Feature | Available Formats | Catalogue Number | QAB124155_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Parasitic Gastroenteritis EQA Programme
Feature | Available Formats | Catalogue Number | QAP124154_1 | QAP124154_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Respiratory I EQA Programme
Feature | Available Formats | Catalogue Number | QAV164188_1 | QAV164188_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory I Plus EQA Programme
Feature | Available Formats | Catalogue Number | QAM204216_1A | QAM204216_1B |
Total Number of Challenges | 1 | 1 |
Number of Panel Members | 10 | 10 |
Distribution / Testing Period | Q2 | Q4 |
Respiratory II EQA Programme
Feature | Available Formats | Catalogue Number | QAV164189_1 | QAV164189_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory III EQA Programme
Feature | Available Formats | Catalogue Number | QAM174193_1 | QAM174193_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Sepsis EQA Programme
Feature | Available Formats | Catalogue Number | QAB164178_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Sexually Transmitted Infections I EQA Programme
Feature | Available Formats | Catalogue Number | QAB154177_1 | QAB154177_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Sexually Transmitted Infections II EQA Programme
Feature | Available Formats | Catalogue Number | QAM174201_1 | QAM174201_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Transplantation EQA Programme
Feature | Available Formats | Catalogue Number | QAM174198_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Viral Gastroenteritis EQA Programme
Feature | Available Formats | Catalogue Number | QAV124152_1 | QAV124152_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Click to view / hide
Respiratory Diseases
Adenovirus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV054133_1 | QAV054133_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Atypical Mycobacterium EQA Programme
Feature | Available Formats | Catalogue Number | QAB194208_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q1 |
Bordetella pertussis DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAB094132_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Chlamydia psittaci EQA Programme
Feature | Available Formats | Catalogue Number | QAB134165_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q2 |
Chlamydophila pneumoniae EQA Programme
Feature | Available Formats | Catalogue Number | QAB084107_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Coronavirus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV064137_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Group A Streptococcus (GAS) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAB234226_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Influenza Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV064138_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q4 |
Influenza virus A and B RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV054134_1 | QAV054134_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Legionella spp. EQA Programme
Feature | Available Formats | Catalogue Number | QAB044122_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q1 |
MERS Coronavirus EQA Programme
Feature | Available Formats | Catalogue Number | QAV154181_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q2 |
Measles and Mumps EQA Programme
Feature | Available Formats | Catalogue Number | QAV144171_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Metapneumovirus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV054135_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q2 |
Mycobacterium Tuberculosis Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAB194209_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Mycobacterium tuberculosis DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAB014129_1 | QAB014129_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Mycoplasma pneumoniae EQA Programme
Feature | Available Formats | Catalogue Number | QAB174192_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Parainfluenza Virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV064136_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAF114144_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Respiratory I EQA Programme
Feature | Available Formats | Catalogue Number | QAV164188_1 | QAV164188_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory I Plus EQA Programme
Feature | Available Formats | Catalogue Number | QAM204216_1A | QAM204216_1B |
Total Number of Challenges | 1 | 1 |
Number of Panel Members | 10 | 10 |
Distribution / Testing Period | Q2 | Q4 |
Respiratory II EQA Programme
Feature | Available Formats | Catalogue Number | QAV164189_1 | QAV164189_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory III EQA Programme
Feature | Available Formats | Catalogue Number | QAM174193_1 | QAM174193_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory Syncytial Virus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV054142_1 | QAV054142_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Rhinovirus RNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV064143_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
SARS-CoV-2 Antigen Testing EQA Programme
Feature | Available Formats | Catalogue Number | QAS214224_1A | QAS214224_1B | QAS214224_1C | QAS214224_1D |
Total Number of Challenges | 1 | 1 | 1 | 1 |
Number of Panel Members | 5 | 5 | 5 | 5 |
Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
SARS-CoV-2 EQA Programme
Feature | Available Formats | Catalogue Number | QAV204215_1A | QAV204215_1B | QAV204215_1C | QAV204215_1D |
Total Number of Challenges | 1 | 1 | 1 | 1 |
Number of Panel Members | 5 | 5 | 5 | 5 |
Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
Click to view / hide
Sexually Transmitted Infections
Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAB174191_1 | QAB174191_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Herpes Simplex Virus Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAV164184_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q1 |
Herpes simplex virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV994105_1 | QAV994105_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Human Papillomavirus (Preservcyt) EQA Programme
Feature | Available Formats | Catalogue Number | QAV094130_1 | QAV094130_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 12 | 6 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Human Papillomavirus (Surepath) EQA Programme
Feature | Available Formats | Catalogue Number | QAV184204_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 12 |
Distribution / Testing Period | Q3 |
Mycoplasma genitalium EQA Programme
Feature | Available Formats | Catalogue Number | QAB184205_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Sexually Transmitted Infections I EQA Programme
Feature | Available Formats | Catalogue Number | QAB154177_1 | QAB154177_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Sexually Transmitted Infections II EQA Programme
Feature | Available Formats | Catalogue Number | QAM174201_1 | QAM174201_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Syphilis EQA Programme
Feature | Available Formats | Catalogue Number | QAB154180_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Trichomonas vaginalis EQA Programme
Feature | Available Formats | Catalogue Number | QAP184202_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Click to view / hide
Transplant Associated Diseases
Adenovirus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV054133_1 | QAV054133_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
BK virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV144166_1 | QAV144166_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Cytomegalovirus Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV144169_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Cytomegalovirus Whole Blood EQA Programme
Feature | Available Formats | Catalogue Number | QAV124150_1 | QAV124150_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV024121_1 | QAV024121_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus Whole Blood EQA Programme
Feature | Available Formats | Catalogue Number | QAV134161_1 | QAV134161_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Cytomegalovirus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV014120_1 | QAV014120_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Herpes Virus 6 DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV084119_1 | QAV084119_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
JC virus DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAV074106_1 | QAV074106_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Torque Teno Virus EQA Programme
Feature | Available Formats | Catalogue Number | QAV184203_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 6 |
Distribution / Testing Period | Q4 |
Toxoplasma gondii DNA EQA Programme
Feature | Available Formats | Catalogue Number | QAP044123_1 | QAP044123_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Transplantation EQA Programme
Feature | Available Formats | Catalogue Number | QAM174198_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Click to view / hide
Typing
Bacterial 16S EQA Programme
Feature | Available Formats | Catalogue Number | QAB164183_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Cytomegalovirus Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV144169_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Enterovirus Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV164185_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
HBV Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV124160_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV134167_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAV024131_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme
Feature | Available Formats | Catalogue Number | QAV114146_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
Hepatitis B virus Genotype EQA Programme
Feature | Available Formats | Catalogue Number | QAV064118_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Hepatitis C virus Genotype EQA Programme
Feature | Available Formats | Catalogue Number | QAV034117_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Herpes Simplex Virus Drug Resistance EQA Programme
Feature | Available Formats | Catalogue Number | QAV164184_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q1 |
Influenza Typing EQA Programme
Feature | Available Formats | Catalogue Number | QAV064138_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q4 |
MALDI-TOF EQA Programme
Feature | Available Formats | Catalogue Number | QAB124155_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Methicillin Resistant Staphylococcus aureus Typing (epidemiology and outbreak studies) EQA Programme
Feature | Available Formats | Catalogue Number | QAB074128_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Staphylococcus aureus spa EQA Programme
Feature | Available Formats | Catalogue Number | QAB134164_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 6 |
Distribution / Testing Period | Q3 |
Click to view / hide
EQA Pilots
Plasmodium spp. (Malaria) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214218_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Babesia spp. (Babesiosis) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214219_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Francisella tularensis EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAB214220_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Group A Streptococcus (GAS) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAB234226_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
HIV Dried Blood Spot EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV214221_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Hepatitis B Virus Dried Blood Spot EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV214223_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Hepatitis C Virus Dried Blood Spot EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV214222_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Poxviruses EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV224225_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAP214217_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Viral Metagenomics NGS EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAV204213_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
Click to view / hide
New Programme
Joint Infection EQA Pilot Study
Feature | Available Formats | Catalogue Number | QAM244227_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |